Mercer Global Advisors
HQL icon

Mercer Global Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Mercer Global Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,108
Closed -$262K – 3710
2026
Q1 		$262K Buy
16,108
+5,581
+53% +$93.3K ﹤0.01% 2574
2025
Q4 		$177K Buy
+10,527
New +$177K ﹤0.01% 2600

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Penserra Capital Management
Penserra Capital Management Orinda, California $13B AUM 71.83% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.3B AUM 39.4% 1-Year Est. Return
Needham Investment Management
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Flagship Harbor Advisors
Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
180 Wealth Advisors
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Mercer Global Advisors's HQL Position: Q2 2026 in Review

Mercer Global Advisors sold out of abrdn Life Sciences Investors (HQL) in Q2 2026, closing a stake of 16,108 shares — an estimated $262K sold.

Mercer Global Advisors first reported a position in HQL in Q4 2025 and held it in 2 quarters. The position peaked at $262K in Q1 2026. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Mercer Global Advisors reported no remaining abrdn Life Sciences Investors position as of Q2 2026 after selling out during the quarter.
  • Mercer Global Advisors sold 16,108 abrdn Life Sciences Investors shares in Q2 2026, an estimated $262K.
  • Mercer Global Advisors first reported a position in abrdn Life Sciences Investors in Q4 2025 and held it in 2 quarters.
  • Mercer Global Advisors's abrdn Life Sciences Investors position peaked at $262K in Q1 2026.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.